Inventor

Charles Q. Meng

Inventor
Alpharetta, GA, US

Overview

37→
Patents
2003–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 37 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
A61KPreparations for medical, dental or toiletry purposes20%
C07DHeterocyclic compounds19%
A01NPreservation of bodies of humans or animals or plants or parts thereof10%
C07CAcyclic or carbocyclic compounds10%
Y02ATechnologies for adaptation to climate change3%
C07HSugars2%
C07KPeptides2%
A01PBiocidal, pest repellant, pest attractant or plant growth regulatory activity of chemical compounds or preparations1%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
PatentTitleYear
10,857,121Use of malononitrile compounds for protecting animals from parasites202010,793,604Anthelmintic depsipeptide compounds202010,433,552Process for the preparation of isoxazoline compounds201910,344,056Anthelmintic depsipeptide compounds201910,251,863Parasiticidal compositions comprising indole derivatives, methods and uses thereof201910,155,725Anthelmintic compounds and compositions and method of using thereof201810,081,656Anthelmintic depsipeptide compounds20189,776,986'Parasiticidal compositions comprising indole derivatives, methods and uses thereof'20179,695,129'Parasiticidal compositions comprising benzimidazole derivatives, methods and uses thereof'20179,447,084'Antiparisitic and pesticidal isoxazoline compounds'20169,359,305'Parasiticidal compositions comprising benzimidazole derivatives, methods and uses thereof'20169,273,007'Processes for the preparation of 1-aryl-5-alkyl pyrazole compounds'20169,249,102'Anthelmintic compounds and compositions and method of using thereof'20169,173,404'Compositions comprising an aryl pyrazole and a substituted imidazole, methods and uses thereof'20159,133,209'Insecticidal 4-amino-thieno[2,3-D]-pyrimidine compounds and methods of their use'20159,125,407'Compositions comprising an aryl pyrazole and a substituted imidazole, methods and uses thereof'20159,000,187'Parasiticidal compositions comprising benzimidazole derivatives, methods and uses thereof'20158,946,270'Amido-pyridyl ether compounds and compositions and their use against parasites'20158,937,185'Processes for the preparation of 1-aryl-5-alkyl pyrazole compounds'20158,846,569'Pesticidal bis-organosulfur compounds'20148,642,636'Dimeric 1-arylpyrazole derivatives for use against ectoparasites, agricultural pests, and household pests'20148,426,460'Dimeric avermectin and milbemycin derivatives'20137,897,776'Sulfonamide containing compounds for treatment of inflammatory disorders'20117,375,252'Compounds and method for the inhibition of the expression of VCAM-1'20087,371,895'Salt forms of poorly soluble probucol esters and ethers'20087,271,274'Phenolic antioxidants for the treatment of disorders including arthritis, asthma and coronary artery disease'20077,202,247'1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders'20077,183,317'Compounds and methods to increase plasma HDL cholesterol levels and improve HDL functionality'20077,173,129'Sulfonamide-substituted chalcone derivatives and their use to treat diseases'20077,094,801'Chalcone derivatives and their use to treat diseases'20067,078,431'1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders'20066,960,683'Salt forms of poorly soluble probucol esters and ethers'20056,881,860'Compounds and methods to increase plasma HDL cholesterol levels and improve HDL functionality'20056,852,878'Thioketals and thioethers for inhibiting the expression of VCAM-1'20056,828,447'Compounds and methods for the inhibition of the expression of VCAM-1'20046,608,101'1, 3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders'20036,602,914'Compounds and methods for the inhibition of the expression of VCAM-1'2003

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2003–2008Patents assigned to ATHEROGENICS INC (13)· patent assignee history
2003–2008Based in Alpharetta, GA, US· patent location history
2007–2011Based in Duluth, GA, US· patent location history
2013–2016Patents assigned to MERIAL LTD (10)· patent assignee history
2013–2015Patents assigned to MENG CHARLES Q (6)· patent assignee history
2013–2018Based in Johns Creek, GA, US· patent location history
2014–2020Patents assigned to BASF SE (2)· patent assignee history
2015–2020Patents assigned to MERIAL INC (15)· patent assignee history
2015–2020Based in Grayson, GA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MERIAL INC152015–2020
ATHEROGENICS INC132003–2008
MERIAL LTD102013–2016
MENG CHARLES Qself62013–2015
BASF SE22014–2020
Locations
LocationPatentsSpan
Alpharetta, Georgia, US132003–2008
Grayson, Georgia, US122015–2020
Johns Creek, Georgia, US102013–2018
Duluth, Georgia, US22007–2011